Shepherd Kaplan Krochuk’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio IDXG Stock Details IDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,088	Closed	-$195K	–	454
2015 Q3	$195K	Hold	1,088	–	–	0.05%	282
2015 Q2	$156K	Buy	1,088 +544	+100%	+$75.5K	0.03%	339
2015 Q1	$73K	Hold	544	–	–	0.01%	373
2014 Q4	$97K	Sell	544 -394	-42%	-$70.1K	0.02%	422
2014 Q3	$225K	Buy	938 +176	+23%	+$58.8K	0.03%	417
2014 Q2	$334K	Sell	762 -159	-17%	-$73.4K	0.04%	301
2014 Q1	$422K	Sell	921 -36	-4%	-$18.7K	0.05%	237
2013 Q4	$460K	Buy	957 +44	+5%	+$21.5K	0.06%	212
2013 Q3	$440K	Buy	913 +70	+8%	+$33.5K	0.07%	220
2013 Q2	$396K	Buy	+843	New	+$382K	0.08%	235

Other funds holding IDXG

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Shepherd Kaplan Krochuk's IDXG Position: Q4 2015 in Review

Shepherd Kaplan Krochuk sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q4 2015, closing a stake of 1,088 shares — an estimated $195K sold.

Shepherd Kaplan Krochuk first reported a position in IDXG in Q2 2013 and held it in 10 quarters. The position peaked at $460K in Q4 2013. 19 funds tracked by Wall St. Rank hold IDXG as of Q4 2015.

Shepherd Kaplan Krochuk reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
Shepherd Kaplan Krochuk sold 1,088 Interpace Biosciences, Inc. Common Stock shares in Q4 2015, an estimated $195K.
Shepherd Kaplan Krochuk first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2013 and held it in 10 quarters.
Shepherd Kaplan Krochuk's Interpace Biosciences, Inc. Common Stock position peaked at $460K in Q4 2013.
19 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q4 2015.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2015, filed 16 Feb 2016.